Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea
· Delayed Price · Currency is KRW 4,555.00
-95.00 (-2.04%)
Feb 21, 2025, 3:30 PM KST
Cellid, Revenue
Cellid, had revenue of 1.37B KRW in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to 2.28B, up 375.71% year-over-year.
Revenue (ttm)
2.28B
Revenue Growth
+375.71%
P/S Ratio
29.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
96.12B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,364.39B |
| Celltrion | 2,876.25B |
| Yuhan | 2,008.84B |
| SK Biopharmaceuticals | 511.33B |
| SK bioscience | 201.30B |
| Hanmi Pharm. | 1,495.50B |
| Hanall Biopharma | 134.24B |
| Hanmi Science | 1,283.65B |